Literature DB >> 14764940

MALDI-TOF mass spectrometry: a versatile tool for high-performance DNA analysis.

Christian Jurinke1, Paul Oeth, Dirk van den Boom.   

Abstract

Matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS) has developed during the past decade into a versatile tool for biopolymer analysis. The aim of this review is to summarize this development and outline the applications, which have been enabled for routine use in the field of nucleic acid analysis. These include the analysis of mutations, the resequencing of amplicons with a known reference sequence, and the quantitative analysis of gene expression and allelic frequencies in complex DNA mixtures.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14764940     DOI： 10.1385/MB:26:2:147

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN： 1073-6085            Impact factor:   2.695


  75 in total

Review 1.  Candidate-gene approaches for studying complex genetic traits: practical considerations.

Authors:  Holly K Tabor; Neil J Risch; Richard M Myers
Journal:  Nat Rev Genet       Date:  2002-05       Impact factor: 53.242

Review 2.  Advances in proteome analysis by mass spectrometry.

Authors:  T J Griffin; D R Goodlett; R Aebersold
Journal:  Curr Opin Biotechnol       Date:  2001-12       Impact factor: 9.740

3.  Automated genotyping using the DNA MassArray technology.

Authors:  Christian Jurinke; Dirk van den Boom; Charles R Cantor; Hubert Köster
Journal:  Methods Mol Biol       Date:  2002

4.  Infrared MALDI mass spectrometry of large nucleic acids.

Authors:  S Berkenkamp; F Kirpekar; F Hillenkamp
Journal:  Science       Date:  1998-07-10       Impact factor: 47.728

5.  Investigations of the metastable decay of DNA under ultraviolet matrix-assisted laser desorption/ionization conditions with post-source-decay analysis and hydrogen/deuterium exchange.

Authors:  J Gross; A Leisner; F Hillenkamp; S Hahner; M Karas; J Schäfer; F Lützenkirchen; E Nordhoff
Journal:  J Am Soc Mass Spectrom       Date:  1998-09       Impact factor: 3.109

6.  High level multiplex genotyping by MALDI-TOF mass spectrometry.

Authors:  P Ross; L Hall; I Smirnov; L Haff
Journal:  Nat Biotechnol       Date:  1998-12       Impact factor: 54.908

7.  Recovery of nucleic acids from immobilized biotin-streptavidin complexes using ammonium hydroxide and applications in MALDI-TOF mass spectrometry.

Authors:  C Jurinke; D van den Boom; V Collazo; A Lüchow; A Jacob; H Köster
Journal:  Anal Chem       Date:  1997-03-01       Impact factor: 6.986

8.  Rapid screening of genetic polymorphisms using buccal cell DNA with detection by matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  Y H Liu; J Bai; Y Zhu; X Liang; D Siemieniak; P J Venta; D M Lubman
Journal:  Rapid Commun Mass Spectrom       Date:  1995       Impact factor: 2.419

9.  Matrix-assisted laser desorption/ionization mass spectrometry (MALDI) of endonuclease digests of RNA.

Authors:  S Hahner; H C Lüdemann; F Kirpekar; E Nordhoff; P Roepstorff; H J Galla; F Hillenkamp
Journal:  Nucleic Acids Res       Date:  1997-05-15       Impact factor: 16.971

10.  High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  K H Buetow; M Edmonson; R MacDonald; R Clifford; P Yip; J Kelley; D P Little; R Strausberg; H Koester; C R Cantor; A Braun
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205
View more
  51 in total

1.  Large-scale validation of single nucleotide polymorphisms in gene regions.

Authors:  Matthew R Nelson; George Marnellos; Stefan Kammerer; Carolyn R Hoyal; Michael M Shi; Charles R Cantor; Andreas Braun
Journal:  Genome Res       Date:  2004-08       Impact factor: 9.043

2.  Detection of thrombophilic mutations related to spontaneous abortions by a multiplex SNaPshot method.

Authors:  Svetlana Madjunkova; Marija Volk; Borut Peterlin; Dijana Plaseska-Karanfilska
Journal:  Genet Test Mol Biomarkers       Date:  2011-10-24

3.  Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib.

Authors:  Geoffrey R Oxnard; Yelena Y Janjigian; Maria E Arcila; Camelia S Sima; Samantha L Kass; Gregory J Riely; William Pao; Mark G Kris; Marc Ladanyi; Christopher G Azzoli; Vincent A Miller
Journal:  Clin Cancer Res       Date:  2011-08-10       Impact factor: 12.531

4.  The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer.

Authors:  Shu Wang; Bing Yu; Chiu Chin Ng; Belinda Mercorella; Christina I Selinger; Sandra A O'Toole; Wendy A Cooper
Journal:  Transl Lung Cancer Res       Date:  2015-04

5.  Liquid chromatography-electrospray ionization mass spectrometry for simultaneous detection of mtDNA length and nucleotide polymorphisms.

Authors:  Herbert Oberacher; Harald Niederstätter; Walther Parson
Journal:  Int J Legal Med       Date:  2006-09-06       Impact factor: 2.686

6.  Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.

Authors:  Libero Santarpia; Yuan Qi; Katherine Stemke-Hale; Bailiang Wang; Elliana J Young; Daniel J Booser; Frankie A Holmes; Joyce O'Shaughnessy; Beth Hellerstedt; John Pippen; Tatiana Vidaurre; Henry Gomez; Vicente Valero; Gabriel N Hortobagyi; W Fraser Symmans; Giulia Bottai; Angelo Di Leo; Ana M Gonzalez-Angulo; Lajos Pusztai
Journal:  Breast Cancer Res Treat       Date:  2012-04-27       Impact factor: 4.872

7.  New correction algorithms for multiple comparisons in case-control multilocus association studies based on haplotypes and diplotype configurations.

Authors:  Kazuharu Misawa; Shoogo Fujii; Toshimasa Yamazaki; Atsushi Takahashi; Junichi Takasaki; Masao Yanagisawa; Yozo Ohnishi; Yusuke Nakamura; Naoyuki Kamatani
Journal:  J Hum Genet       Date:  2008-07-24       Impact factor: 3.172

8.  The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients.

Authors:  Xiang-Ping Li; Ji-Ye Yin; Ying Wang; Hui He; Xi Li; Wei-Jing Gong; Juan Chen; Chen-Yue Qian; Yi Zheng; Fang Li; Tao Yin; Zhi-Cheng Gong; Bo-Ting Zhou; Yu Zhang; Ling Xiao; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2014-05-23

9.  Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping.

Authors:  Maria Arcila; Christopher Lau; Khedoudja Nafa; Marc Ladanyi
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

10.  Transcript profiling of candidate genes in testis of pigs exhibiting large differences in androstenone levels.

Authors:  Eli Grindflek; Ingunn Berget; Maren Moe; Paul Oeth; Sigbjørn Lien
Journal:  BMC Genet       Date:  2010-01-25       Impact factor: 2.797
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.